Nanomedicine; Intensive care; Transfusiology
Andrey Nikolaevich Belousov graduated from Kharkov Medical Institute in 1988. Doctor of Medicine degree in specialty – Anesthesiology and Intensive Care since 2004. The title dissertation: “Extracorporeal hemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales diseases”. Author of new medicine products – nanotechnology preparations based on magnetite nanoparticles (Fe3O4) of the size 6-12 nm (www.nanolab.com.ua): the oral form – Micromage-B (the biologically active additive officially registered in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporeal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application – ICNB (intracorporal nanosorbent). A.N. Belousov is the author new method of extracorporeal hemocorrection using magnet-controlled sorbent (MCS-B). Author a new program (PHUAS) for estimation degree of the severity of the patient. They published more than 230 scientific works on the results application of nanotechnology preparation in experimental and practical medicine. He has got 7 patents for the invention. Now Andrey Belousov – the Head of Laboratory Applied Nanotechnologies in Ukraine, DM, Professor of Department Anesthesiology, Intensive Care, Transfusiology and Hematology Kharkov Medical Academy of Postgraduate Education.
Research Interest: Nanomedicine; Intensive care; Transfusiology